Global Pharmaceuticals & Biotech Breakout Stocks

Elanco Animal Health

Market Cap: US$8.5b

An animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.

Avidity Biosciences

Market Cap: US$5.9b

A biopharmaceutical company, engages in the delivery of RNA therapeutics called antibody oligonucleotide conjugates (AOCs).

Mirum Pharmaceuticals

Market Cap: US$3.3b

A biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases.

Tarsus Pharmaceuticals

Market Cap: US$2.1b

A commercial stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for eye care in the United States.

Liquidia

Market Cap: US$1.8b

A biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States.

Ascletis Pharma

Market Cap: HK$14.0b

A biotechnology company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical products in Mainland China.

ANI Pharmaceuticals

Market Cap: US$1.7b

A biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally.

Xeris Biopharma Holdings

Market Cap: US$1.2b

A commercial-stage biopharmaceutical company, engages in developing and commercializing therapies for chronic endocrine and neurological diseases in Illinois.

Collegium Pharmaceutical

Market Cap: US$1.1b

A specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management.

Cronos Group

Market Cap: CA$1.4b

A cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally.

Pell Bio-Med Technology

Market Cap: NT$23.0b

A biomedical company, engages in the development of cell culture technologies and techniques for therapeutic applications.

Rigel Pharmaceuticals

Market Cap: US$600.2m

A biotechnology company, engages in discovering, developing, and providing therapies that enhance the lives of patients with hematologic disorders and cancer.

Curiox Biosystems

Market Cap: ₩822.7b

Manufactures and sells medical appliances and instruments in South Korea.

Tonix Pharmaceuticals Holding

Market Cap: US$522.6m

A biopharmaceutical company, focuses on developing and commercializing therapeutics to treat and prevent human disease.

180 Life Sciences

Market Cap: US$514.5m

A clinical stage biotechnology company, focuses on developing therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases in the United States.

Verastem

Market Cap: US$505.3m

A development-stage biopharmaceutical company, focuses on developing and commercializing drugs for the treatment of cancer in the United States.

Emergent BioSolutions

Market Cap: US$475.4m

A life sciences company, provides preparedness and response solutions for accidental, deliberate, and naturally occurring public health threats in the United States.

Cryoport

Market Cap: US$405.6m

Provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and reproductive medicine markets worldwide.

Pyridam Farma

Market Cap: Rp6.1t

Engages in the development, production, and trading of pharmaceuticals primarily in Indonesia.

Assembly Biosciences

Market Cap: US$373.3m

A biotechnology company, develops therapeutic candidates for the treatment of viral diseases worldwide.

Mabpharm

Market Cap: HK$2.7b

A biopharmaceutical company, engages in research, development, production, and commercialization of drugs and biosimilar for cancers and autoimmune diseases in the People’s Republic of China.

Genomictree

Market Cap: ₩430.9b

A biomarker-based molecular diagnostics company, develops and commercializes molecular diagnostic products for the detection of cancer and various infectious diseases.

Design Therapeutics

Market Cap: US$274.5m

A clinical-stage biopharmaceutical company, research, designs, develops, and commercializes small molecule therapeutic drugs for the treatment of genetic diseases in the United States.

Puma Biotechnology

Market Cap: US$245.3m

A biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally.

Adocia

Market Cap: €160.7m

A clinical-stage biotechnology company, researches and develops formulations of pre-approved therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases.

CANbridge Pharmaceuticals

Market Cap: HK$709.0m

A biopharmaceutical company, engages in the research, development, and commercialization of therapies for rare diseases and oncology indications worldwide.

BioNxt Solutions

Market Cap: CA$110.4m

Engages in research, development, manufacture, and sale of next generation drug formulations and delivery systems in Austria, Germany, and Switzerland.

Steminent Biotherapeutics

Market Cap: NT$2.0b

A stem cell research and development company, develops and manufactures novel cellular therapeutics for the treatment of diseases with unmet or under-served medical needs.

Cognition Therapeutics

Market Cap: US$63.1m

A clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina.

Memphis Pharmaceuticals & Chemical Industries

Market Cap: ج.م2.9b

A drug holding company, produces and sells pharmaceutical products for human and veterinary use in Egypt and internationally.

Decibel Cannabis

Market Cap: CA$69.2m

An integrated cannabis company, engages in the cannabis cultivation in Canada.

C21 Investments

Market Cap: CA$67.1m

An integrated cannabis company, cultivates, processes, distributes, and sells cannabis and hemp-derived consumer products in the United States.

AccuStem Sciences

Market Cap: US$35.5m

A clinical stage diagnostics company, focuses on developing and commercializing a suite of novel genomic tests for oncology care.

GeneBioTech Ltd

Market Cap: ₩44.2b

Engages in the manufacture and sale of feed additives and functional food in South Korea.

Equillium

Market Cap: US$31.6m

A clinical-stage biotechnology company, develops therapeutics to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need in the United States.

Fusion Antibodies

Market Cap: UK£16.5m

A contract research organization, engages in the research, development, and manufacture of recombinant proteins and antibodies primarily for cancer and infectious diseases in the United Kingdom, the rest of Europe, North America, and internationally.